Science


Peer-Reviewed Scientific Validation

Grounded in decades of analytical chemistry, laser-tissue interaction physics, and mass spectrometry innovation and backed by peer-reviewed literature, conference presentations, and federal R&D grants. 

Grant-Funded R&D & Commercialization Track Record

Active Company R&D (Laser Bioanalytics LLC)

NIH SBIR Phase I Award (Active / Funded): Photochemical Tissue Processing for MALDI Mass Spectrometry Imaging — Validating spatially resolved on-tissue photochemical modification for lipid double-bond localization and structural isomer mapping. (Award #GM156259)

Founder SBIR/STTR Track Record ($5.25M in Phase I & II Awards)

Compact Tunable IR Lasers for MALDI: Phase I and Phase II ( A Compact Tunable Infrared Laser for MALDI MS ).

Prototype infrared optical parametric oscillator (OPO)
Prototype OPOTEK infrared optical parametric oscillator (in LSU purple) with a fixed wavelength Er:YAG laser in the background.

High-Repetition-Rate IR Lasers for MS: Phase I and Phase II ( A High-Repetition-Rate IR Laser for Mass Spectrometry ).
Single-Cell Nanoscale Laser Ablation MS:Infrared Laser Desorption Ion Mobility MS: Phase I and Phase II ( Infrared Laser Desorption Ion Mobility Mass Spectrometer ). Phase I ( Single Cell Chemical Imaging via Nanoscale IR Ablation – Mass Spectrometry ) and Phase II ( Single Cell Analysis via Nanoscale Tip-Enhanced Laser Ablation Mass Spectrometry ).

Core Research Areas

mid-infrared laser ablation microdissection

Non-thermal, mid-infrared laser desorption/ablation coupled with native mass spectrometry and ion mobility spectrometry. Proves mid-infrared pulses ablate biomolecules without thermal denaturation, keeping fragile non-covalent protein complexes intact.

Deep ultraviolet laser ablation Microdissection

Non-thermal, short-wavelength laser desorption/ablation coupled with native mass spectrometry and ion mobility spectrometry. Proves high-photon-energy DUV pulses ablate biomolecules without thermal denaturation, keeping fragile non-covalent protein complexes intact.

Photochemical Tissue Processing
  • ASMS 2026: Photochemical Tissue Processing for MALDI Lipid Imaging
Photochemical Tissue Processing for MALDI Lipid Imaging
ASMS 2026, ThP 260, Photochemical Tissue Processing for MALDI Lipid Imaging

Collaborative Research & Beta Validation

We actively collaborate with academic mass spectrometry laboratories, core facilities, and clinical researchers to validate new tissue matrices, benchmark analytical sensitivity, and co-develop NIH SBIR/STTR Phase I and Phase II proposals.